Trial · NCT03238235
Results by group132
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 132
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline to Visit 11 in Total Fibrosis (%) on Log Scale, Comparing the Histology of Muscle Biopsies | Givinostat | -0.017 | 95% Confidence Interval -0.367 to 0.333 | log[percentage of total fibrosis] | |
| Mean Change From Baseline to Visit 11 in Total Fibrosis (%) on Log Scale, Comparing the Histology of Muscle Biopsies | Placebo | -0.054 | 95% Confidence Interval -0.507 to 0.399 | log[percentage of total fibrosis] | |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Vastus Lateralis and Soleus | Givinostat | Vastus Lateralis | 0.017 | 95% Confidence Interval -0.053 to 0.086 | log[percentage of fat in muscle] |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Vastus Lateralis and Soleus | Placebo | Vastus Lateralis | 0.064 | 95% Confidence Interval -0.019 to 0.147 | log[percentage of fat in muscle] |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Vastus Lateralis and Soleus | Givinostat | Soleus | -4.287 | 95% Confidence Interval -6.126 to -2.447 | log[percentage of fat in muscle] |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Vastus Lateralis and Soleus | Placebo | Soleus | -4.021 | 95% Confidence Interval -6.404 to -1.637 | log[percentage of fat in muscle] |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Givinostat | Whole Thigh | 0.642 | 95% Confidence Interval -0.328 to 1.611 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Placebo | Whole Thigh | 1.996 | 95% Confidence Interval 0.813 to 3.180 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Givinostat | Quadriceps | 0.610 | 95% Confidence Interval -0.506 to 1.726 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Placebo | Quadriceps | 2.572 | 95% Confidence Interval 1.227 to 3.918 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Givinostat | Hamstrings | 0.877 | 95% Confidence Interval -0.627 to 2.381 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Placebo | Hamstrings | 1.455 | 95% Confidence Interval -0.400 to 3.309 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Givinostat | Triceps Surae | -0.276 | 95% Confidence Interval -2.862 to 2.310 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Placebo | Triceps Surae | 1.317 | 95% Confidence Interval -1.686 to 4.319 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Givinostat | Pelvis Girdle | 0.584 | 95% Confidence Interval -0.509 to 1.676 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in the Percentage of Fat Fraction of Lower Limb Muscles | Placebo | Pelvis Girdle | 1.471 | 95% Confidence Interval 0.112 to 2.830 | percentage of fat in muscle |
| Mean Change From Baseline to Visit 11 in Cross-sectional Area (CSA), in cm2 of Lower Limb Muscles | Givinostat | whole thigh | 2.782 | 95% Confidence Interval 0.151 to 5.413 | centimeters^2 |
| Mean Change From Baseline to Visit 11 in Cross-sectional Area (CSA), in cm2 of Lower Limb Muscles | Placebo | whole thigh | 2.377 | 95% Confidence Interval -0.820 to 5.575 | centimeters^2 |
| Mean Change From Baseline to Visit 11 in Cross-sectional Area (CSA), in cm2 of Lower Limb Muscles | Givinostat | quadriceps | 0.997 | 95% Confidence Interval -0.169 to 2.163 | centimeters^2 |
| Mean Change From Baseline to Visit 11 in Cross-sectional Area (CSA), in cm2 of Lower Limb Muscles | Placebo | quadriceps | 1.082 | 95% Confidence Interval -0.329 to 2.494 | centimeters^2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03238235/results